Kemper (KMPR) Financials

Kemper’s recent financial trend has weakened sharply after a profitable 2024. The company generated quarterly net income attributable to common shareholders of $71.3 million in Q1 2024 and $75.4 million in Q2 2024, but results deteriorated to losses in the second half of 2025 and into 2026. The Q2 2026 loss was particularly severe, largely because of a $460 million impairment charge.

Revenue remains substantial, but premiums earned have generally declined. Premiums earned fell from $1.29 billion in Q3 2022 to $1.01 billion in Q2 2026. Q2 2026 total revenue of $1.09 billion was below the $1.23 billion reported in Q2 2025 and the $1.19 billion reported in Q2 2024. Investment gains continue to provide meaningful support, although they are more volatile than insurance premium revenue.

• Debt has been reduced materially. Long-term debt declined from approximately $2.09 billion in Q3 2022, when Kemper also carried $449.9 million of short-term debt, to $944.5 million in Q2 2026 with no short-term debt reported. This improves financial flexibility and reduces refinancing risk.
• Kemper continues to generate positive operating cash flow. Operating cash flow was $30.5 million in Q2 2026 and $88.8 million in Q1 2026, following $175 million in Q4 2025 and $180 million in Q1 2025. Although the trend is weakening, positive cash generation provides some support for ongoing operations and capital obligations.
• The share count has declined. Weighted-average basic shares fell from roughly 64.4 million in Q1 2024 to 58.9 million in Q2 2026. Share repurchases, particularly in Q3 2025, have helped reduce the number of shares outstanding and could enhance per-share results if profitability recovers.
• The dividend has remained consistent. Quarterly common dividends were generally $0.31 per share in 2024 and $0.32 per share in 2025 and Q1 2026. Maintaining the dividend signals continued capital-return discipline, although the recent losses make future coverage an important consideration.
• The investment portfolio remains large and relatively stable. Trading account securities were $7.26 billion in Q2 2026, compared with $7.00 billion in Q1 2024 and $7.18 billion in Q3 2022. Investment gains have supported revenue, but the dependence on investment performance can make earnings more volatile.
• Balance-sheet leverage has improved, but insurance liabilities remain substantial. Total liabilities were $9.75 billion in Q2 2026 versus $10.22 billion in Q3 2022, while claims and claim expenses increased from $2.72 billion to $12.72 billion under the standardized data presentation. Investors should monitor claims development and reserve adequacy closely.
• Q2 2026 produced a $466 million consolidated net loss. The loss attributable to common shareholders was $464.8 million, or negative $7.90 per diluted share, compared with a $1.7 million loss in Q1 2026 and $72.6 million of earnings in the restated Q2 2025 period.
• The $460 million impairment charge overwhelmed operating results. Q2 2026 non-interest expenses reached $1.56 billion, including the impairment, compared with $1.14 billion in Q1 2026 and $1.14 billion in Q2 2025. The charge substantially reduced reported equity and highlights the risk of further asset write-downs.
• Profitability has not been sustained. After positive earnings in Q1 and Q2 2024, Kemper posted losses of $21.0 million in Q3 2025, $8.0 million in Q4 2025, $1.7 million in Q1 2026 and $464.8 million in Q2 2026. Q2 2026’s pretax loss of $467 million contrasts with pretax income of $87.5 million in the restated Q2 2025 period.
• Operating cash flow is deteriorating while financing cash flow remains negative. Operating cash flow declined from $180 million in Q1 2025 to $30.5 million in Q2 2026. Kemper also used $45.3 million for financing activities in Q2 2026, including debt repayment and dividends, contributing to an $11.4 million quarterly decline in cash.

Overall, the statements show a mixed investment case. Lower debt, a reduced share count, positive operating cash flow and a maintained dividend are constructive. However, the sharp return to losses, declining premium revenue, weakening cash generation and sizable impairment charge indicate that Kemper’s turnaround remains incomplete. Investors should focus on claims trends, premium growth, operating profitability and whether future cash flow can comfortably support dividends and debt reduction.